TRDA

Entrada Therapeutics, Inc. - Common Stock (TRDA)

About Entrada Therapeutics, Inc. - Common Stock (TRDA)

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which provides of a class of medicines that engages in intracellular targets. Its Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. The company was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Details

Daily high

$5.07

Daily low

$4.52

Price at open

$5.05

52 Week High

$16.45

52 Week Low

$4.11

Market cap

197.0M

Dividend yield

Volume

305,317

Avg. volume

428,346

P/E ratio

-1.28

Entrada Therapeutics, Inc. - Common Stock News